argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
GlobeNewswire
ADHERE data show VYVGART*®* Hytrulo has potential to be first advancement for CIDP patients in 30 years
Real-world data..